Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

250c7be197ded5a4ea93d0f.lhZRbRojYMBPeI5FAsyMPi_V7OWRFV8jm5NKQNKWhP8.4nVpDyppKJcQLeNyU4rdfRqNlZH1cilTqfk-d5_g9rPSTyAMTkpY7QMu4Q~570fc520d20029c0b5fa829a2a84aa04
Aug. 21 TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating MT
Aug. 13 Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating MT
Aug. 13 Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130 MT
Jul. 28 UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating MT
Jul. 28 Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating MT
Jul. 23 Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating MT
Jul. 22 Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating MT
Jul. 17 Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says MT
Jul. 17 JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating MT
Jul. 17 Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating MT
Jul. 17 BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating MT
Jul. 17 Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating MT
Jul. 17 Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating MT
Jul. 17 Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating MT
Jul. 16 Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109 MT
Jul. 06 Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120 MT
Jul. 01 Baird Initiates Abbott Laboratories at Outperform With $121 Price Target MT
Jun. 12 BofA Adjusts Price Target on Abbott Laboratories to $102 From $120 MT
May. 27 Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating MT
May. 05 Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase MT
Apr. 22 Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell… Zonebourse
Apr. 22 Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113 MT
Apr. 21 Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating MT
Apr. 21 Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating MT
Apr. 20 Argus Cuts Abbott Laboratories' Price Target to $125 From $140 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+17.64%
+13%
+19.36%
+7.88%
+33.01%
+7.45%
+38.85%
+10.58%
+20.09%
Average +18.65%
Weighted average by Cap. +17.55%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
102.23USD
Average target price
120.26USD
Spread / Average Target
+17.64%
High Price Target
135.00USD
Spread / Highest target
+32.06%
Low Price Target
103.00USD
Spread / Lowest Target
+0.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABL Stock
  5. Consensus Abbott Laboratories
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!